We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$232M
AUM Growth
-$7.38M
Cap. Flow
-$16.7M
Cap. Flow %
-7.19%
Top 10 Hldgs %
29.39%
Holding
116
New
2
Increased
6
Reduced
34
Closed
9

Top Buys

Rank Stock Value
1
TVRD
Tvardi Therapeutics
TVRD
+$3.76M
2
RCKT icon
Rocket Pharmaceuticals
RCKT
+$523K
3
PVH icon
PVH
PVH
+$327K
4
CMCSA icon
Comcast
CMCSA
+$58.7K
5
NFLX icon
Netflix
NFLX
+$11.4K

Top Sells

Rank Stock Value
1
AGTC
Applied Genetic Technologies Corporation
AGTC
+$4.54M
2
QCOM icon
Qualcomm
QCOM
+$2.2M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$1.71M
4
KKR icon
KKR & Co
KKR
+$1.63M
5
MGNX icon
MacroGenics
MGNX
+$1.32M

Sector Composition

Rank Sector Weight
1 Healthcare 29.01%
2 Communication Services 22.71%
3 Energy 13.38%
4 Industrials 12.54%
5 Technology 5.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
76
Merck
MRK
$366B
$449K 0.19%
8,908
– –
NFLX icon
77
Netflix
NFLX
$340B
$432K 0.19%
37,750
+1,000
+3% +$11.4K
LBRDA
78
DELISTED
Liberty Broadband Class A
LBRDA
$424K 0.18%
8,218
– –
TROW icon
79
T. Rowe Price
TROW
$23.7B
$424K 0.18%
5,930
– –
Z icon
80
Zillow
Z
$8.02B
$376K 0.16%
16,000
– –
PH icon
81
Parker-Hannifin
PH
$125B
$361K 0.16%
3,727
– –
LLL
82
DELISTED
L3 Technologies, Inc.
LLL
$359K 0.16%
3,000
– –
MDSO
83
DELISTED
Medidata Solutions, Inc.
MDSO
$350K 0.15%
7,100
– –
PG icon
84
Procter & Gamble
PG
$334B
$318K 0.14%
4,000
– –
XLV icon
85
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
$288K 0.12%
4,000
– –
IBM icon
86
IBM
IBM
$222B
$282K 0.12%
2,144
– –
ED icon
87
Consolidated Edison
ED
$39.8B
$280K 0.12%
4,350
– –
PVH icon
88
PVH
PVH
$3.49B
$273K 0.12%
+3,700
New +$327K
WMT icon
89
Walmart Inc
WMT
$820B
$267K 0.12%
13,065
– –
GS icon
90
Goldman Sachs
GS
$301B
$257K 0.11%
1,425
– –
IONS icon
91
Ionis Pharmaceuticals
IONS
$10.1B
$254K 0.11%
4,100
-31,750
-89% -$1.71M
UAA icon
92
Under Armour
UAA
$2.18B
$242K 0.1%
6,000
– –
ZG icon
93
Zillow
ZG
$8.23B
$208K 0.09%
8,000
– –
BRK.B icon
94
Berkshire Hathaway Class B
BRK.B
$1.08T
$205K 0.09%
1,550
– –
IMMP
95
Immutep
IMMP
$56.1M
– –
-156,000
Closed -$660K
MGNX icon
96
MacroGenics
MGNX
$263M
– –
-61,415
Closed -$1.32M
OXY icon
97
Occidental Petroleum
OXY
$59.1B
– –
-6,661
Closed -$440K
SPY icon
98
State Street SPDR S&P 500 ETF Trust
SPY
$825B
– –
-1,925
Closed -$369K
SU icon
99
Suncor Energy
SU
$76.5B
– –
-33,765
Closed -$902K
ICPT
100
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-4,400
Closed -$730K
1 2 3
4
5

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q4 2015 Portfolio in Review

As of Q4 2015, Private Capital Advisors held 116 positions worth $232M, down 3.1% from $239M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Private Capital Advisors withdrew a net $16.7M in Q4 2015, closing 9 positions and reducing 34 holdings. Its most notable exit was MacroGenics, an estimated $1.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 29% a quarter earlier, followed by Communication Services and Energy.

Against the trend, Private Capital Advisors opened a new position in Tvardi Therapeutics worth $4.16M.

  • Private Capital Advisors's largest Q4 2015 buy was Tvardi Therapeutics: 6,857 shares worth $4.16M.
  • Private Capital Advisors added most to Rocket Pharmaceuticals in Q4 2015, an estimated $523K increase.
  • Private Capital Advisors's biggest Q4 2015 reduction was Applied Genetic Technologies Corporation, cutting an estimated $4.54M.
  • Private Capital Advisors fully exited MacroGenics in Q4 2015, selling an estimated $1.32M.
  • Private Capital Advisors's ten largest holdings make up 29% of its $232M portfolio in Q4 2015.
  • Private Capital Advisors opened 2 new positions and closed 9 in Q4 2015.
  • Private Capital Advisors's portfolio value fell 3.1% quarter-over-quarter to $232M.

Based on Private Capital Advisors's 13F filing for Q4 2015, filed 22 Jan 2016.